Insights

Global Expansion Potential Rapid Medical has demonstrated regulatory traction and market validation through 2026 DISTALS trial results presented at ESOC and Chinese approval for the TIGERTRIEVER device, signaling readiness to expand into US, Europe, and APAC markets via distributors and regional partnerships.

Clinical Validation Full DISTALS trial results provide robust clinical evidence supporting the safety and effectiveness of their adjustable, brain visible neurovascular devices, enabling value based conversations with stroke centers and procurement teams.

Strategic Partnerships Past investments and partnerships, notably MicroPort's $20M investment in 2019 and the appointment of a President for Americas in 2021, suggest a proven route for co development and regional distribution to accelerate US, Canada, and LATAM growth.

Product Portfolio Fit The TIGERTRIEVER revascularization device and COMANECI embolization assist device address ruptured wide neck intracranial aneurysms and revascularization needs, offering surgeons devices that are fully visible and adjustable in the brain, a compelling differentiator for neurovascular centers.

Commercial Readiness With a focused team size and increasing visibility through ESOC participation, plus a strategic product portfolio, Rapid Medical is positioned to target mid to large stroke centers and neurovascular specialists seeking innovative technologies and evidence backed outcomes.

Rapid Medical Tech Stack

Rapid Medical uses 8 technology products and services including html5media, ISO 13485, Microsoft PowerPoint, and more. Explore Rapid Medical's tech stack below.

  • html5media
    Audio, Video, Graphics
  • ISO 13485
    Certificates
  • Microsoft PowerPoint
    Editors
  • Lodash
    Javascript Libraries
  • Skrollr
    Javascript Libraries
  • Priority Hints
    Performance
  • HSTS
    Security
  • Google Tag Manager
    Tag Management

Media & News

Rapid Medical's Email Address Formats

Rapid Medical uses at least 1 format(s):
Rapid Medical Email FormatsExamplePercentage
First@rapid-medical.comJohn@rapid-medical.com
55%
First.Last@rapid-medical.comJohn.Doe@rapid-medical.com
31%
FirstL@rapid-medical.comJohnD@rapid-medical.com
12%
Last@rapid-medical.comDoe@rapid-medical.com
2%

Frequently Asked Questions

Where is Rapid Medical's headquarters located?

Minus sign iconPlus sign icon
Rapid Medical's main headquarters is located at P.o.b. 337 Yokneam Illit, Northern District 20692 Israel. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Rapid Medical's official website and social media links?

Minus sign iconPlus sign icon
Rapid Medical's official website is rapid-medical.com and has social profiles on LinkedIn.

What is Rapid Medical's NAICS code?

Minus sign iconPlus sign icon
Rapid Medical's NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does Rapid Medical have currently?

Minus sign iconPlus sign icon
As of April 2026, Rapid Medical has approximately 146 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Ceo: R. E.Cto: G. K.Cfo: M. E.. Explore Rapid Medical's employee directory with LeadIQ.

What industry does Rapid Medical belong to?

Minus sign iconPlus sign icon
Rapid Medical operates in the Medical Equipment Manufacturing industry.

What technology does Rapid Medical use?

Minus sign iconPlus sign icon
Rapid Medical's tech stack includes html5mediaISO 13485Microsoft PowerPointLodashSkrollrPriority HintsHSTSGoogle Tag Manager.

What is Rapid Medical's email format?

Minus sign iconPlus sign icon
Rapid Medical's email format typically follows the pattern of First@rapid-medical.com. Find more Rapid Medical email formats with LeadIQ.

When was Rapid Medical founded?

Minus sign iconPlus sign icon
Rapid Medical was founded in 2008.

Rapid Medical

Medical Equipment ManufacturingNorthern District, Israel51-200 Employees

Rapid Medical is an Israel-based medical equipment manufacturer that develops neurovascular interventional devices. The company is based in Yokneam Illit, Israel, and its workforce ranges from 51 to 200 employees. Its devices are designed to be fully visible and adjustable within the brain in order to tailor stroke-related procedures to individual patients. Recent milestones include Chinese regulatory approval for the TIGERTRIEVER revascularisation device in 2023. In May 2026, Rapid Medical announced full results from the DISTALS randomized controlled trial presented at the European Stroke Organisation Conference.

Section iconCompany Overview

Headquarters
P.o.b. 337 Yokneam Illit, Northern District 20692 Israel
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Rapid Medical's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Rapid Medical's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.